Skip to main content
Clinical Trials/CTRI/2024/04/065773
CTRI/2024/04/065773
Not yet recruiting
Phase 2

a comparative study of the efficacy of the topical triamcinolone acetonide versus topical latanoprost in combination with microneedling and narrowband ultraviolet B phototherapy in the treatment of vitiligo - NI

mgm medical college and hospital0 sites0 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Not specified
Sponsor
mgm medical college and hospital
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • A patient who voluntarily agreed and given consent to participate in the study.
  • A patient who has two or more non segmental, stable vitiligo lesions with similar degree of progression measuring 5cm2 or more present over the face, trunk or limbs.
  • All patients with vitiligo presenting to MGM medical college and hospital.

Exclusion Criteria

  • Local disease such as folliculitis.
  • Patient on anticoagulants and blood thinners
  • Keloidal tendencies
  • HIV, Hepatitis B or C, or otherwise
  • immunocompromised patient.
  • Unrealistic expectations of patients

Outcomes

Primary Outcomes

Not specified

Similar Trials